These get you in trouble fast: Copying protocols from forums without medical director signoff Buying from gray-market suppliers Leaving the medical director out of key decisions Making big, unsupported claims in your marketing Skipping patient consent or not documenting it well Forgetting to track lot numbers and product info Letting non-clinical staff answer medical questions Ignoring your state's rules on scope and compliance Mistake: Treating Peptides Like Retail Wellness Items Even with high demand, peptides aren't just supplements or retail items for your shelf
If you compete at the sanctioned level, discuss this with your clinician before starting any protocol
Usual results are less pain and fewer flares
Copper peptide GHK-Cu has been studied extensively for its role in accelerating tissue repair, making it relevant not just cosmetically but in recovery-focused medical settings too
The FDA said in a federal notice Wednesday it will ask a panel of outside advisers to review seven peptides at a meeting in July, specifically whether they should be added to a list of substances that can be safely produced by pharmacies
The results illustrated that the two targeting peptides exerted strong protective effects on HaCaT from oxidative damage